RxTROSPECT is a regulatory precedent identification tool that provides extensive analytics on US FDA and EU EMA oncology approvals (original approvals and follow-on indications).
➤ Who is RxTROSPECT for?
Drug development teams who are planning oncology development strategies and need to:
• De-risk regulatory strategy through easy to access regulatory precedent.
• Plan future discussions with the FDA and global health authorities on strategy, trial design, unmet medical need and scientific advice.
• Enhance their understanding of how drugs are approved in the US and Europe and the nuances that come with that.
• Enhance their overall regulatory intelligence offering.
➤ Why is RxTROSPECT valuable?
Our users (from top 10 oncology companies to pre-revenue biotech) all report saving tremendous amounts of time in precedent identification, enabling them to focus on assessment and strategy. We have a renewal rate of >90% over the past five years which shows the value our users are seeing in the tool and its offering.
➤ What does RxTROSPECT reveal?
Precedent on indication, study design, pivotal study phase and size, regulatory pathways, key efficacy and safety data for all oncology approvals (original approvals and new indications).
➤ How can I access RxTROSPECT?
Visit rxtrospect.com or email us at theteam@rxtrospect.com to learn how RxTROSPECT users are leveraging our solution to expedite development of informed regulatory strategies and, ultimately, drug development strategies.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Virtual, Chicago,il 60661,united States
- Industry
- Business Intelligence Platforms
- Website
- rxtrospect.com
- Keywords
- IT Consulting.
- HQ
- Chicago, IL
Rxtrospect Oncology Analytics Questions
Rxtrospect Oncology Analytics's website is rxtrospect.com
Rxtrospect Oncology Analytics's LinkedIn profile is https://www.linkedin.com/company/rxtrospect
Rxtrospect Oncology Analytics has
1 employees.
View email and phone details for 1
employees at Rxtrospect Oncology Analytics.
Rxtrospect Oncology Analytics's industry is
Business Intelligence Platforms
Rxtrospect Oncology Analytics's top competitors are
Altai Oncology,
Affinitiv Advertising,
Mentalee Ug (Haftungsbeschränkt),
Easy Edi,
Healthtech Solutions,
Ardence Consulting,
Certis Oncology Solutions, Inc.,
Xcovery Holdings, Inc.,
Citius Pharmaceuticals, Inc.,
Touch, The Black Breast Cancer Alliance.
Rxtrospect Oncology Analytics's categories are Business Intelligence Platforms
Rxtrospect Oncology Analytics's founding year is 2017
